21-deoxycortisol has been researched along with Endocrine System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gau, M; Hasegawa, T; Hashimoto, A; Ishige, N; Kashimada, K; Konishi, K; Morio, T; Nakatani, H; Sutani, A; Tajima, T; Takasawa, K; Tsuji-Hosokawa, A; Watanabe, K; Yajima, H | 1 |
1 other study(ies) available for 21-deoxycortisol and Endocrine System Diseases
| Article | Year |
|---|---|
The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Androgens; Androstenedione; Chromatography, Liquid; Cortodoxone; Endocrine System Diseases; Female; Humans; Hydrocortisone; Infant, Newborn; Male; Neonatal Screening; Steroids; Tandem Mass Spectrometry | 2022 |